CRISPR Therapeutics AG - stock earnings
CRSP Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 30, 2024 AfterMarket | - / -1.3206000000 | - | - / 28.7 million | - |
CRSP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 89.3 million USD | 200.0 million USD |
| 2023Q3 | -112.2 million USD | ? USD |
| 2023Q2 | -77.7 million USD | 70.0 million USD |
| 2023Q1 | -53.1 million USD | 100.0 million USD |
| 2022Q4 | -110.6 million USD | 6000 USD |
| 2022Q3 | -174.5 million USD | 94000 USD |
| 2022Q2 | -185.8 million USD | 158000 USD |
| 2022Q1 | -179.2 million USD | 178000 USD |
| 2021Q4 | -141.2 million USD | 12.3 million USD |
| 2021Q3 | -127.2 million USD | 329000 USD |
| 2021Q2 | 759.2 million USD | 900.2 million USD |
| 2021Q1 | -113.2 million USD | 202000 USD |
| 2020Q4 | -107.0 million USD | 194000 USD |
| 2020Q3 | -92.4 million USD | 148000 USD |
| 2020Q2 | -79.7 million USD | 44000 USD |
| 2020Q1 | -69.7 million USD | 157000 USD |
| 2019Q4 | 30.5 million USD | 77.0 million USD |
| 2019Q3 | 138.4 million USD | 211.9 million USD |
| 2019Q2 | -53.7 million USD | 318000 USD |
| 2019Q1 | -48.4 million USD | 328000 USD |
| 2018Q4 | -47.6 million USD | 115000 USD |
| 2018Q3 | -50.7 million USD | 563000 USD |
| 2018Q2 | -38.4 million USD | 1.1 million USD |
| 2018Q1 | -28.3 million USD | 1.4 million USD |
| 2017Q4 | 141000 USD | 32.3 million USD |
| 2017Q3 | -24.7 million USD | 2.4 million USD |
| 2017Q2 | -22.3 million USD | 3.6 million USD |
| 2017Q1 | -21.5 million USD | 2.7 million USD |
| 2016Q4 | 17.1 million USD | 2.3 million USD |
| 2016Q3 | -14.7 million USD | 1.5 million USD |
| 2016Q2 | -17.2 million USD | 795000 USD |
| 2016Q1 | -8.4 million USD | 476000 USD |
| 2015Q4 | -12.3 million USD | 247000 USD |
| 2015Q3 | -6.4 million USD | ? USD |
| 2014Q4 | -6.3 million USD | ? USD |
CRSP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -153.6 million USD | 370.0 million USD |
| 2022 | -650.2 million USD | 436000 USD |
| 2021 | 377.7 million USD | 913.1 million USD |
| 2020 | -348.9 million USD | 543000 USD |
| 2019 | 66.9 million USD | 289.6 million USD |
| 2018 | -165.0 million USD | 3.1 million USD |
| 2017 | -68.4 million USD | 41.0 million USD |
| 2016 | -23.2 million USD | 5.2 million USD |
| 2015 | -25.8 million USD | 247000 USD |
| 2014 | -6.8 million USD | ? USD |
CRSP
Price: $55.07
52 week price:
Earnings Per Share: -1.94 USD
P/E Ratio: -15.08
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.2 million
Ebitda: -23.2 millionMarket Capitalization: 4.6 billion